De-escalation of Combination Drug Therapy in Inflammatory Bowel Disease Patients

被引：0
|
作者：
Saleh, Adam A. [1 ]
Waghela, Rajdeepsingh [2 ]
Garza, Manuel [3 ]
Stading, Rachel [3 ]
Miroballi, Natalia [3 ]
Moskow, Joshua [4 ]
Thurston, Theresa [4 ]
Abraham, Bincy [5 ]
机构：
[1] Texas A&M Hlth Sci Ctr, Engn Med, Med Sch, Houston, TX USA
[2] Houston Methodist Hosp, Houston, TX 77030 USA
[3] Texas A&M Hlth Sci Ctr, Med Sch, Houston, TX USA
[4] Texas A&M Hlth Sci Ctr, Houston, TX USA
[5] Houston Methodist Acad Inst, Houston, TX USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2022年 / 117卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
S993
引用
收藏
页码：S722 / S722
页数：1
相关论文
共 50 条
  • [1] De-escalation of Therapy in Inflammatory Bowel Disease
    Frias Gomes C.
    Colombel J.-F.
    Torres J.
    [J]. Current Gastroenterology Reports, 2018, 20 (8)
  • [2] De-escalation of Therapy in Patients with Quiescent Inflammatory Bowel Disease
    Miyatani, Yusuke
    Kobayashi, Taku
    [J]. GUT AND LIVER, 2023, 17 (02) : 181 - 189
  • [3] De-escalation of medical therapy in inflammatory bowel disease
    Gomes, Catarina Frias
    Chapman, Thomas P.
    Satsangi, Jack
    [J]. CURRENT OPINION IN PHARMACOLOGY, 2020, 55 : 73 - 81
  • [4] De-escalation of biological therapy in Inflammatory Bowel Disease patients following prior escalation
    Thomas, P.
    Smits, L.
    Groen, M. Te
    West, R.
    Russel, M.
    Jansen, J.
    Romkens, T.
    Hoentjen, F.
    [J]. JOURNAL OF CROHNS & COLITIS, 2021, 15 : S086 - S086
  • [5] De-escalation of immunomodulator and biological therapy in inflammatory bowel disease
    Chapman, Thomas P.
    Gomes, Catarina Frias
    Louis, Edouard
    Colombel, Jean-Frederic
    Satsangi, Jack
    [J]. LANCET GASTROENTEROLOGY & HEPATOLOGY, 2020, 5 (01): : 63 - 79
  • [6] De-escalation of biological therapy in inflammatory bowel disease patients following prior dose escalation
    Thomas, Pepijn W. A.
    Smits, Lisa J. T.
    Te Groen, Maarten
    West, Rachel L.
    Russel, Maurice G. V. M.
    Jansen, Jeroen M.
    Romkens, Tessa E. H.
    Hoentjen, Frank
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (05) : 488 - 495
  • [7] De-escalation of biological therapy in inflammatory bowel disease: Benefits and risks
    Fredericks, E.
    Watermeyer, G.
    [J]. SAMJ SOUTH AFRICAN MEDICAL JOURNAL, 2019, 109 (10): : 745 - 749
  • [8] Evaluation of de-escalation of anti-TNF-α therapy in inflammatory bowel disease
    Sedano Munoz, Rocio
    Quera Pino, Rodrigo
    Lubascher Correa, Jaime
    Pizarro Jofre, Gonzalo
    Simian Marin, Daniela
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2019, 42 (02): : 133 - 140
  • [9] Inflammatory bowel disease in the clinic: Escalation and de-escalation of therapy: A longitudinal case-based discussion
    Begun, Jakob
    [J]. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2016, 31 : 12 - 13
  • [10] EFFECTIVENESS OF DOSE DE-ESCALATION OF BIOLOGIC THERAPY IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW
    Little, Derek H.
    Tabatabavakili, Sahar
    Shaffer, Seth
    Weizman, Adam V.
    Nguyen, Geoffrey C.
    Targownik, Laura E.
    [J]. GASTROENTEROLOGY, 2020, 158 (06) : S670 - S671
12345